Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1990 2
1991 2
1993 1
1994 3
1995 13
1996 30
1997 44
1998 32
1999 46
2000 52
2001 63
2002 77
2003 68
2004 78
2005 75
2006 106
2007 103
2008 85
2009 113
2010 104
2011 124
2012 134
2013 150
2014 142
2015 128
2016 138
2017 141
2018 170
2019 153
2020 212
2021 203
2022 167
2023 143
2024 161
2025 201
2026 33

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,138 results

Results by year

Filters applied: . Clear all
Page 1
Mouse Behavior in the Open-field Test after Meloxicam Administration.
Antiorio AT, Alemán-Laporte J, Zanatto DA, Pereira MAA, Gomes MS, Wadt D, Yamamoto PK, Bernardi MM, Mori CM. Antiorio AT, et al. J Am Assoc Lab Anim Sci. 2022 May 1;61(3):270-274. doi: 10.30802/AALAS-JAALAS-21-000046. Epub 2022 Jan 31. J Am Assoc Lab Anim Sci. 2022. PMID: 35101160 Free PMC article.
One hypothesis for the result was potential differences in formulation between commercial brands of meloxicam. Thus, this current study aimed to evaluate the effects of 3 different commercial brands of meloxicam (20 mg/kg) in the general activity of mice using the o …
One hypothesis for the result was potential differences in formulation between commercial brands of meloxicam. Thus, this current stu …
Meloxicam.
Khalil NY, Aldosari KF. Khalil NY, et al. Profiles Drug Subst Excip Relat Methodol. 2020;45:159-197. doi: 10.1016/bs.podrm.2019.10.006. Epub 2019 Dec 12. Profiles Drug Subst Excip Relat Methodol. 2020. PMID: 32164967
Meloxicam, an oxicam derivative: 4-Hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1,2- benzothiazine-3-carboxamide 1,1-dioxide, is a nonsteroidal anti-inflammatory drug (NSAID). ...It may also be given by rectal suppository in doses similar to those used orally. The reported …
Meloxicam, an oxicam derivative: 4-Hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1,2- benzothiazine-3-carboxamide 1,1-dioxide, is a no …
Meloxicam.
Noble S, Balfour JA. Noble S, et al. Drugs. 1996 Mar;51(3):424-30; discussion 431-32. doi: 10.2165/00003495-199651030-00007. Drugs. 1996. PMID: 8882380 Review.
Meloxicam is a new nonsteroidal anti-inflammatory drug (NSAID) developed for the treatment of rheumatoid arthritis and osteoarthritis. ...Meloxicam was at least as well tolerated as piroxicam, diclofenac or naproxen overall but had improved gastrointestinal tolerabi …
Meloxicam is a new nonsteroidal anti-inflammatory drug (NSAID) developed for the treatment of rheumatoid arthritis and osteoarthritis …
[Meloxicam clinical effects].
Shavlovskaya OA, Bokova IA, Shavlovskiy NI. Shavlovskaya OA, et al. Zh Nevrol Psikhiatr Im S S Korsakova. 2022;122(1):36-42. doi: 10.17116/jnevro202212201136. Zh Nevrol Psikhiatr Im S S Korsakova. 2022. PMID: 35175701 Russian.
Considering these circumstances, the NSAID meloxicam (Amelotex) can be recommended for the treatment of various genesis pain syndromes. ...Recent studies concern intravenous (i/v) meloxicam (30 mg) administration with moderate and severe postoperative pain syndrome. …
Considering these circumstances, the NSAID meloxicam (Amelotex) can be recommended for the treatment of various genesis pain syndrome …
Bupivacaine and Meloxicam.
[No authors listed] [No authors listed] Am J Health Syst Pharm. 2021 Oct 25;78(21):1922-1929. doi: 10.1093/ajhp/zxab304. Am J Health Syst Pharm. 2021. PMID: 34398228 No abstract available.
Meloxicam-induced thrombocytopenia.
Ranieri MM, Bradley EF, Simon AB. Ranieri MM, et al. Pharmacotherapy. 2014 Feb;34(2):e14-7. doi: 10.1002/phar.1372. Epub 2013 Nov 11. Pharmacotherapy. 2014. PMID: 24214337
However, only one previously documented case of meloxicam-associated thrombocytopenia has been reported in the literature. We describe an 84-year-old woman who developed a case of immune-mediated thrombocytopenia that was attributed to meloxicam therapy. The patient …
However, only one previously documented case of meloxicam-associated thrombocytopenia has been reported in the literature. We describ …
Bupivacaine/Meloxicam Prolonged Release: A Review in Postoperative Pain.
Blair HA. Blair HA. Drugs. 2021 Jul;81(10):1203-1211. doi: 10.1007/s40265-021-01551-9. Epub 2021 Jul 6. Drugs. 2021. PMID: 34228280 Review.
Prolonged-release (PR; as ascribed in the EU) or extended-release (as ascribed in the USA) bupivacaine/meloxicam (HTX-011; hereafter referred to as bupivacaine/meloxicam PR; Zynrelef()) is a synergistic fixed-dose combination (FDC) of the local anaesthetic bupivacai …
Prolonged-release (PR; as ascribed in the EU) or extended-release (as ascribed in the USA) bupivacaine/meloxicam (HTX-011; hereafter …
Meloxicam-associated anaphylactic reaction.
Bavbek S, Erkekol FO, Dursun B, Misirligil Z. Bavbek S, et al. J Investig Allergol Clin Immunol. 2006;16(5):317-20. J Investig Allergol Clin Immunol. 2006. PMID: 17039673 Free article.
Anaphylactic reaction to meloxicam has never been reported to date. We report 2 cases of meloxicam-induced anaphylactic reaction with no sensitivity to another selective cyclooxygenase 2 inhibitor. ...
Anaphylactic reaction to meloxicam has never been reported to date. We report 2 cases of meloxicam-induced anaphylactic reacti …
Meloxicam-induced capillaritis with positive rechallenge.
Ben Salem C, Chahed F, Sahnoun D, Slim R, Sriha B, Denguezli M. Ben Salem C, et al. Br J Clin Pharmacol. 2023 Nov;89(11):3460-3462. doi: 10.1111/bcp.15892. Epub 2023 Aug 31. Br J Clin Pharmacol. 2023. PMID: 37653568 Free article. No abstract available.
3,138 results